Free Trial

HealthEquity, Inc. (NASDAQ:HQY) Stake Increased by Ranger Investment Management L.P.

HealthEquity logo with Medical background
Remove Ads

Ranger Investment Management L.P. increased its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 17.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 305,883 shares of the company's stock after acquiring an additional 45,130 shares during the quarter. HealthEquity makes up about 1.9% of Ranger Investment Management L.P.'s portfolio, making the stock its 21st biggest holding. Ranger Investment Management L.P. owned approximately 0.35% of HealthEquity worth $29,349,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of HQY. Smartleaf Asset Management LLC raised its position in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares during the period. Louisiana State Employees Retirement System lifted its position in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock valued at $2,322,000 after buying an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in HealthEquity by 0.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after buying an additional 100 shares during the period. State of Michigan Retirement System raised its stake in shares of HealthEquity by 0.5% in the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after acquiring an additional 100 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of HealthEquity by 0.6% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock worth $1,850,000 after acquiring an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the completion of the transaction, the director now directly owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is currently owned by company insiders.

HealthEquity Trading Down 0.6 %

Shares of NASDAQ HQY traded down $0.51 on Monday, reaching $81.69. 248,454 shares of the company traded hands, compared to its average volume of 758,865. The stock has a market capitalization of $7.07 billion, a PE ratio of 74.94, a P/E/G ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50 day moving average of $97.63 and a 200 day moving average of $96.42.

Analysts Set New Price Targets

A number of analysts have issued reports on HQY shares. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their target price for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research reissued an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday. The Goldman Sachs Group lowered their target price on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Wells Fargo & Company increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Finally, KeyCorp lowered their price objective on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Monday, March 24th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $112.58.

Read Our Latest Research Report on HealthEquity

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads